Pan-cancer landscape of AID-related mutations, composite mutations, and their potential role in the ICI response

Abstract Activation-induced cytidine deaminase, AICDA or AID, is a driver of somatic hypermutation and class-switch recombination in immunoglobulins. In addition, this deaminase belonging to the APOBEC family may have off-target effects genome-wide, but its effects at pan-cancer level are not well e...

Full description

Bibliographic Details
Main Authors: Isaias Hernández-Verdin, Kadir C. Akdemir, Daniele Ramazzotti, Giulio Caravagna, Karim Labreche, Karima Mokhtari, Khê Hoang-Xuan, Matthieu Peyre, Franck Bielle, Mehdi Touat, Ahmed Idbaih, Alex Duval, Marc Sanson, Agustí Alentorn
Format: Article
Language:English
Published: Nature Portfolio 2022-12-01
Series:npj Precision Oncology
Online Access:https://doi.org/10.1038/s41698-022-00331-2
_version_ 1797642073239715840
author Isaias Hernández-Verdin
Kadir C. Akdemir
Daniele Ramazzotti
Giulio Caravagna
Karim Labreche
Karima Mokhtari
Khê Hoang-Xuan
Matthieu Peyre
Franck Bielle
Mehdi Touat
Ahmed Idbaih
Alex Duval
Marc Sanson
Agustí Alentorn
author_facet Isaias Hernández-Verdin
Kadir C. Akdemir
Daniele Ramazzotti
Giulio Caravagna
Karim Labreche
Karima Mokhtari
Khê Hoang-Xuan
Matthieu Peyre
Franck Bielle
Mehdi Touat
Ahmed Idbaih
Alex Duval
Marc Sanson
Agustí Alentorn
author_sort Isaias Hernández-Verdin
collection DOAJ
description Abstract Activation-induced cytidine deaminase, AICDA or AID, is a driver of somatic hypermutation and class-switch recombination in immunoglobulins. In addition, this deaminase belonging to the APOBEC family may have off-target effects genome-wide, but its effects at pan-cancer level are not well elucidated. Here, we used different pan-cancer datasets, totaling more than 50,000 samples analyzed by whole-genome, whole-exome, or targeted sequencing. AID mutations are present at pan-cancer level with higher frequency in hematological cancers and higher presence at transcriptionally active TAD domains. AID synergizes initial hotspot mutations by a second composite mutation. AID mutational load was found to be independently associated with a favorable outcome in immune-checkpoint inhibitors (ICI) treated patients across cancers after analyzing 2000 samples. Finally, we found that AID-related neoepitopes, resulting from mutations at more frequent hotspots if compared to other mutational signatures, enhance CXCL13/CCR5 expression, immunogenicity, and T-cell exhaustion, which may increase ICI sensitivity.
first_indexed 2024-03-11T13:55:51Z
format Article
id doaj.art-10e4ff93711e45efae0a1c2b4a7ff33b
institution Directory Open Access Journal
issn 2397-768X
language English
last_indexed 2024-03-11T13:55:51Z
publishDate 2022-12-01
publisher Nature Portfolio
record_format Article
series npj Precision Oncology
spelling doaj.art-10e4ff93711e45efae0a1c2b4a7ff33b2023-11-02T07:00:15ZengNature Portfolionpj Precision Oncology2397-768X2022-12-016111410.1038/s41698-022-00331-2Pan-cancer landscape of AID-related mutations, composite mutations, and their potential role in the ICI responseIsaias Hernández-Verdin0Kadir C. Akdemir1Daniele Ramazzotti2Giulio Caravagna3Karim Labreche4Karima Mokhtari5Khê Hoang-Xuan6Matthieu Peyre7Franck Bielle8Mehdi Touat9Ahmed Idbaih10Alex Duval11Marc Sanson12Agustí Alentorn13Sorbonne Université, Inserm, CNRS, UMR S 1127, Institut du Cerveau et de la Moelle épinière, ICMDepartments of Genomic Medicine and Neurosurgery, University of Texas MD Anderson Cancer CenterDepartment of Medicine and Surgery, University of Milano-BicoccaCancer Data Science Laboratory, Dipartimento di Matematica e Geoscienze, Università degli Studi di TriesteSorbonne Université, Inserm, CNRS, UMR S 1127, Institut du Cerveau et de la Moelle épinière, ICMSorbonne Université, Inserm, CNRS, UMR S 1127, Institut du Cerveau et de la Moelle épinière, ICMSorbonne Université, Inserm, CNRS, UMR S 1127, Institut du Cerveau et de la Moelle épinière, ICMSorbonne Université, Inserm, CNRS, UMR S 1127, Institut du Cerveau et de la Moelle épinière, ICMSorbonne Université, Inserm, CNRS, UMR S 1127, Institut du Cerveau et de la Moelle épinière, ICMSorbonne Université, Inserm, CNRS, UMR S 1127, Institut du Cerveau et de la Moelle épinière, ICMSorbonne Université, Inserm, CNRS, UMR S 1127, Institut du Cerveau et de la Moelle épinière, ICMSorbonne Université, INSERM, Unité Mixte de Recherche Scientifique 938 and SIRIC CURAMUS, Centre de Recherche Saint-Antoine, Equipe Instabilité des Microsatellites et Cancer, Equipe labellisée par la Ligue Nationale contre le CancerSorbonne Université, Inserm, CNRS, UMR S 1127, Institut du Cerveau et de la Moelle épinière, ICMSorbonne Université, Inserm, CNRS, UMR S 1127, Institut du Cerveau et de la Moelle épinière, ICMAbstract Activation-induced cytidine deaminase, AICDA or AID, is a driver of somatic hypermutation and class-switch recombination in immunoglobulins. In addition, this deaminase belonging to the APOBEC family may have off-target effects genome-wide, but its effects at pan-cancer level are not well elucidated. Here, we used different pan-cancer datasets, totaling more than 50,000 samples analyzed by whole-genome, whole-exome, or targeted sequencing. AID mutations are present at pan-cancer level with higher frequency in hematological cancers and higher presence at transcriptionally active TAD domains. AID synergizes initial hotspot mutations by a second composite mutation. AID mutational load was found to be independently associated with a favorable outcome in immune-checkpoint inhibitors (ICI) treated patients across cancers after analyzing 2000 samples. Finally, we found that AID-related neoepitopes, resulting from mutations at more frequent hotspots if compared to other mutational signatures, enhance CXCL13/CCR5 expression, immunogenicity, and T-cell exhaustion, which may increase ICI sensitivity.https://doi.org/10.1038/s41698-022-00331-2
spellingShingle Isaias Hernández-Verdin
Kadir C. Akdemir
Daniele Ramazzotti
Giulio Caravagna
Karim Labreche
Karima Mokhtari
Khê Hoang-Xuan
Matthieu Peyre
Franck Bielle
Mehdi Touat
Ahmed Idbaih
Alex Duval
Marc Sanson
Agustí Alentorn
Pan-cancer landscape of AID-related mutations, composite mutations, and their potential role in the ICI response
npj Precision Oncology
title Pan-cancer landscape of AID-related mutations, composite mutations, and their potential role in the ICI response
title_full Pan-cancer landscape of AID-related mutations, composite mutations, and their potential role in the ICI response
title_fullStr Pan-cancer landscape of AID-related mutations, composite mutations, and their potential role in the ICI response
title_full_unstemmed Pan-cancer landscape of AID-related mutations, composite mutations, and their potential role in the ICI response
title_short Pan-cancer landscape of AID-related mutations, composite mutations, and their potential role in the ICI response
title_sort pan cancer landscape of aid related mutations composite mutations and their potential role in the ici response
url https://doi.org/10.1038/s41698-022-00331-2
work_keys_str_mv AT isaiashernandezverdin pancancerlandscapeofaidrelatedmutationscompositemutationsandtheirpotentialroleintheiciresponse
AT kadircakdemir pancancerlandscapeofaidrelatedmutationscompositemutationsandtheirpotentialroleintheiciresponse
AT danieleramazzotti pancancerlandscapeofaidrelatedmutationscompositemutationsandtheirpotentialroleintheiciresponse
AT giuliocaravagna pancancerlandscapeofaidrelatedmutationscompositemutationsandtheirpotentialroleintheiciresponse
AT karimlabreche pancancerlandscapeofaidrelatedmutationscompositemutationsandtheirpotentialroleintheiciresponse
AT karimamokhtari pancancerlandscapeofaidrelatedmutationscompositemutationsandtheirpotentialroleintheiciresponse
AT khehoangxuan pancancerlandscapeofaidrelatedmutationscompositemutationsandtheirpotentialroleintheiciresponse
AT matthieupeyre pancancerlandscapeofaidrelatedmutationscompositemutationsandtheirpotentialroleintheiciresponse
AT franckbielle pancancerlandscapeofaidrelatedmutationscompositemutationsandtheirpotentialroleintheiciresponse
AT mehditouat pancancerlandscapeofaidrelatedmutationscompositemutationsandtheirpotentialroleintheiciresponse
AT ahmedidbaih pancancerlandscapeofaidrelatedmutationscompositemutationsandtheirpotentialroleintheiciresponse
AT alexduval pancancerlandscapeofaidrelatedmutationscompositemutationsandtheirpotentialroleintheiciresponse
AT marcsanson pancancerlandscapeofaidrelatedmutationscompositemutationsandtheirpotentialroleintheiciresponse
AT agustialentorn pancancerlandscapeofaidrelatedmutationscompositemutationsandtheirpotentialroleintheiciresponse